Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
REST signature
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
REST signature
Glioblastoma
REST signature
Glioblastoma
cisplatin
Sensitive: D – Preclinical
cisplatin
Sensitive
:
D
cisplatin
Sensitive: D – Preclinical
cisplatin
Sensitive
:
D
REST signature
Glioblastoma
REST signature
Glioblastoma
mitomycin
Sensitive: D – Preclinical
mitomycin
Sensitive
:
D
mitomycin
Sensitive: D – Preclinical
mitomycin
Sensitive
:
D
REST signature
Glioblastoma
REST signature
Glioblastoma
ponatinib
Sensitive: D – Preclinical
ponatinib
Sensitive
:
D
ponatinib
Sensitive: D – Preclinical
ponatinib
Sensitive
:
D
REST signature
Glioblastoma
REST signature
Glioblastoma
pazopanib
Sensitive: D – Preclinical
pazopanib
Sensitive
:
D
pazopanib
Sensitive: D – Preclinical
pazopanib
Sensitive
:
D
REST signature
Glioblastoma
REST signature
Glioblastoma
ASP7487
Sensitive: D – Preclinical
ASP7487
Sensitive
:
D
ASP7487
Sensitive: D – Preclinical
ASP7487
Sensitive
:
D
REST signature
Glioblastoma
REST signature
Glioblastoma
Topoisomerase I inhibitor
Sensitive: D – Preclinical
Topoisomerase I inhibitor
Sensitive
:
D
Topoisomerase I inhibitor
Sensitive: D – Preclinical
Topoisomerase I inhibitor
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.